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The β-herpesviridae subfamily member human cytomegalovirus
(HCMV)1 is a major human pathogen (Britt, 2008). Replication of its
double-stranded DNA (dsDNA) genome occurs in the nuclei of infected
cells via a rolling circle processmediated by 11 virally-encoded proteins
(Mercorelli et al., 2008; Pari, 2008). These include a DNA polymerase
holoenzyme composed of a catalytic subunit, pUL54, and a processivity
factor, ppUL44. The latter is a 52-kDa phosphoprotein endowed with a
strong dsDNA-binding ability (Gibson et al., 1981;Weiland et al., 1994)
which stimulates pUL54 catalytic activity by tethering the holoenzymeto the DNA (Ertl and Powell, 1992; Loregian et al., 2003). ppUL44 can be
structurally and functionally divided in an N-terminal domain (aa
1–290), forming a head-to-head homodimeric sliding clamp which
retains all knownppUL44biochemical properties as a processivity factor
in vitro (Loregian et al., 2004; Weiland et al., 1994), and a largely
unfolded C-terminal domain (Appleton et al., 2004), containing the
nuclear localization signal (NLS) responsible for nuclear targeting
(aa 425–431), as well as binding sites for several cellular and viral
proteins (Alvisi et al., 2005; Fulcher et al., 2010; Kim and Ahn, 2010;
Ranneberg-Nilsen et al., 2008). Despite being dispensable for stimulat-
ing pUL54-mediated DNA synthesis in vitro (Weiland et al., 1994),
ppUL44 C-terminus is absolutely required for HCMV replication in cell
culture (KimandAhn,2010; Silva et al., 2010). Duringviral infection, the
protein is phosphorylated on unidentiﬁed residues by UL97, a virus-
encoded kinase, but the effects are unknown (Krosky et al., 2003;
Marschall et al., 2003). ppUL44 also exists as a phosphoprotein inHCMV
infected ﬁbroblasts upon either genetic or pharmacological ablation of
the UL97 kinase, implying that cellular kinase(s) are capable of
phosphorylating it (Krosky et al., 2003). Recent work from our
laboratory supports this hypothesis, whereby we reported that the
Fig. 1. ppUL44 is phosphorylated by cellular kinases in the absence of viral proteins. (A) COS-7 cells were transfected to express ppUL44-FLAG or mock-transfected (mock) and
grown for 24 h before addition of [32P]orthophosphate and incubation for 24 h. Cells were lysed and lysates subjected to immunoprecipitation using an anti-FLAG mouse mAb,
followed by SDS-PAGE, transfer to nitrocellulose and autoradiography (left), or Western blotting using the anti-FLAGmAb (right) as described in the Materials and methods section.
(B) The ppUL44 amino acid sequence was scanned using the NetPhos and GPS software. The putative phosphorylation sites are in the single letter amino acid code, with the
phosphorylated residue in boldface and numbered as per the ppUL44 amino acid sequence. The locationwith respect to the ppUL44 functional domains, the NetPhos score (1) and the
putative phosphorylating kinase according to the GPS software (2) are indicated. Putative CK2 sites are marked by an asterisk, and the acidic residues surrounding them are
underlined. S415 is a potential CK2 phosphorylation site dependent on phosphorylation of S418 (3).
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putative phosphorylation sites, including S413 as a potential target for
protein kinase CK2 (CK2), located immediately upstream of the basic
core of ppUL44's nuclear localization signal (NLS) (Alvisi et al., 2005).
Treatment of cells with tetrabromobenzotriazol, a speciﬁc cell perme-
able CK2 inhibitor (Sarno et al., 2001), or the introduction of the S413A
phosphonull point mutation, reduced NLS activity of ~2 fold when the
C2N motif was fused to the C-terminus of GFP (Alvisi et al., 2005).
Importantly, as reported in the accompanying article, these residues are
highly phosphorylated during HCMV infection (Silva et al. 2011).
Here we investigate ppUL44 phosphorylation by cellular kinases in
detail for the ﬁrst time, using a combination of coimmunoprecipitation
assays in mammalian cells expressing ppUL44, in vitro phosphorylation
assays, and imaging of ppUL44 localization in live cells by confocal laser
scanning microscopy (CLSM). We report that the cellular kinases CK2
and CK1 phosphorylate the ppUL44 C-terminal domain at multiple
residues (S413, S415, S418), in a phosphorylation cascade triggered by
phosphorylation of S413 by CK2, and resulting in enhancement of
nuclear import. In contrast, negative charge at T427, a proposed cyclin-
dependent kinase (cdk) 1 phosphorylation site (Fulcher et al., 2010;
Silva et al., 2011), strongly inhibits nuclear accumulation, whereby both
phosphonull andphosphomimeticpointmutationsof T427affectHCMV
oriLyt-dependent DNA replication, suggesting a functional role for the
site in regulating ppUL44 nuclear transport and protein–protein
interactions during viral infection.
Results
UL44 is phosphorylated in the absence of other viral proteins
The fact that ppUL44 can be immunoprecipitated as a phosphopro-
tein from HCMV infected ﬁbroblast upon either genetic of pharmaco-
logical ablation of UL97 kinase activity (Krosky et al., 2003), suggests
that ppUL44 can be phosphorylated by cellular kinases. To verify this
hypothesis, we expressed a ppUL44-FLAG fusion protein in COS-7 cells
labeled with [32P]orthophosphate in the absence of any other viral
protein. Cellswere subsequently lysed andppUL44 immunoprecipitatedusing anti-FLAG antibody, prior to SDS-PAGE, transfer to nitrocellulose,
and autoradiography orWestern analysis (Fig. 1A). Use of the anti-FLAG
antibody enabled to detect several forms of ppUL44 differing in MW,
consistent with previous reports (Hwang et al., 2000; Mocarski et al.,
1985). Importantly, ppUL44 could also be detected by autoradiography,
indicating that it can be phosphorylated by cellular kinases, even in the
absence of the virus-encoded kinase UL97, as suggested by previous
studies (Alvisi et al., 2005;Kroskyet al., 2003;Marschall et al., 2003), and
of any additional viral protein. Indeed, a scan of ppUL44 sequence using
the software NetPhos identiﬁed 20 putative phosphorylation sites
(NetPhos scoreN0.700), 4 ofwhich are located immediately upstreamof
the ppUL44 NLS [Fig. 1B; see also (Alvisi et al., 2005)]. Putative phos-
phorylation sites include residues S95, T246, S368, and S413, which are
potential targets of phosphorylation by protein kinase CK2. Indeed, they
all bear an acidic residue in position +3 with respect to the target
residue, with potential phosphorylation on S415 being dependent on
phosphorylation of thedownstreamresidueS418 (Pinna, 2002).Despite
not being predicted as a putative phosphorylation site by our bio-
informatic analysis (NetPhos scoreb0.700), residueS199also lieswithin
a CK2 consensus sequence (SELE202) (Pinna, 2002).
Protein kinase CK2 phosphorylates ppUL44
To test if the indicated sites may be targets of CK2-mediated
phosphorylation, bacterially expressed CK2 was incubated with
phosphocellulose-immobilized peptides representing the ﬁve puta-
tive phosphorylation sites (see Table 1) and [33P]-γATP, and
radioactive incorporation determined. As shown in Fig. 2A, only
peptide p5 (RR)KEESDSEDS418, which contains S413, was efﬁciently
phosphorylated by CK2. To identify the exact target residue(s) of CK2-
phosphorylation, we synthesized a peptide corresponding to ppUL44
residues 410–433 covalently bound to resin beads (p7, see Table 1),
incubated it with CK2 in the presence of [33P]-γATP, and then
performed peptide sequencing by Edman degradation. The results
(Fig. 2B) indicate that ppUL44 residue S413 is the predominant target
of CK2 activity within the ppUL44 C-terminal domain. We also tested
the ability of CK2 to phosphorylate recombinant full-length 6His-
Table 1
ppUL44 derived peptides utilized in this study. All peptides apart from p7 are soluble
peptides. Underlining denotes basic residues added on the N-terminal side to allow the
protein kinase assay based on phosphocellulose-paper substrate adsorption. Peptide
p7, corresponding to ppUL44 C-terminal tail, is covalently bound to the resin amino-
PEGA (Novabiochem). The single letter amino acid code is used. Phosphoserine is
indicated as pS.
n. Peptide name Sequence a.a.
p1 RR[92–100] RR-YKTSSKDLT(NH2) 11
p2 RR[196–204] RR-TNGSELEFT(NH2) 11
p3 RR[243–251] RR-RIVTEHDTL(NH2) 11
p4 RR[364–372] RR-HGLSSKEKY(NH2) 11
p5 RR[410–418] RR-KEESDSEDS(NH2) 11
p6 [410–433] KEESDSEDSVTFEFVPNTKKQKAG 24
p7 [410–433] Resin KEESDSEDSVTFEFVPNTKKQKAG 24
p8 [410–433]pS413 KEEpSDSEDSVTFEFVPNTKKQKAG 24
p9 RR[410–420]S413E pS418 RR-KEEEDSEDpSVT 12
261G. Alvisi et al. / Virology 417 (2011) 259–267UL44 as compared to the phosphonull point mutant derivative 6His-
UL44 S413A, with 6His-UL44Δloop, a mutant derivative containing
pointmutationswithin the ppUL44 DNA-binding loop but still bearing
residue S413, as a control (Alvisi et al., 2009; Komazin-Meredith et al.,
2008). As expected, both wild-type 6His-UL44 and its mutant
derivatives were detectable as a dominant band with an apparent
molecular mass of ~60 kDa by Coomassie staining (Fig. 2C). However,
while both 6His-UL44 and 6His-UL44Δloop were efﬁciently phos-
phorylated by recombinant CK2, markedly reduced phosphorylation
was detected for protein 6His-UL44 S413A, suggesting that S413 is theFig. 2. ppUL44 residue S413 can be phosphorylated by CK2 in vitro. (A) Peptides (see Table
radioactivity determined by scintillation counting. (B) peptide p7, representing ppUL44 C-ter
CK2 and [33P]-γATP and analyzed by Edman sequencing. The 33P radioactivity incorporated
x axis, is shown, with the peak at S413. The dashed line indicates the level of aspeciﬁc radioa
for 1 h with [33P]-γATP in the presence or in the absence of recombinant CK2. The mixtures
staining (top panel) or autoradiography (bottom panel). (D) Quantiﬁcation of incorporated
independent experiments +/− SEM.main target of in vitro CK2-mediated phosphorylation within ppUL44
(Fig. 2C and D).
Because ppUL44 can be phosphorylated in vitro by CK2, we
hypothesized that the two proteins could also interact. Since pUL84,
one of the viral interactors of ppUL44 (Alvisi et al., 2006b; Gao et al.,
2008; Strang et al., 2009), can tightly bind to CK2 during viral infection
and can be isolated as an immunocomplex from infected ﬁbroblasts
with both CK2 and ppUL44 (Gao et al., 2008), we tested the ability of
ectopically expressed ppUL44 to interact with CK2α in mammalian
cells, in the absence of other viral proteins. After transfection of COS-7
cells to express GFP-UL44 fusion proteins or GFP alone as a control,
GFP fusions and their cellular binding partners were immunopreci-
pitated using an anti-GFP monoclonal antibody, separated by PAGE,
transferred to nitrocellulose and detected by incubatingwith anti-GFP
and anti-CK2α speciﬁc antibodies. The results show that GFP-UL44,
but not GFP alone, coimmunoprecipitates with CK2α (Fig. 3).
Interestingly, immunoprecipitated GFP-UL44 appeared as a doublet,
with the upper band most likely representing a phosphorylated form
of ppUL44 (Fig. 3, right panel).
The ppUL44 C-terminal domain is the target of multiple phosphorylation
events mediated by CK2 and CK1
S413 is located immediately upstream of ppUL44 NLS which,
together with the putative phosphorylation sites (S413, S415, S418,
and T427), forms a C2N motif, conserved within β-herpesviruses
(Alvisi et al., 2005). The fact that S413 can be phosphorylated by CK21) were incubated for 1 h with recombinant CK2 and [33P]-γATP and the incorporated
minal domain (residues 410–433; see Table 1), was incubated for 1 h with recombinant
at each amino acidic position, indicated with the single letter amino acid code on the
ctivity incorporated. (C) Bacterially puriﬁed 6His-UL44 fusion proteins were incubated
were then separated by SDS-PAGE and proteins visualized by Coomassie Brilliant Blue
radioactivity, as determined by scintillation counting, is shown as the mean of three
Fig. 3. Protein kinase CK2 interacts with ppUL44. HEK293-T cells were transfected to
express GFP or GFP-UL44 as indicated. Cells were harvested 48 h after transfection, cell
lysates prepared, and subjected to immunoprecipitation using an anti-GFP mAb, as
described in the Materials and methods section. After SDS-PAGE and transfer to
nitrocellulose, immunoprecipiated proteins (input shown on the left) were detected
using anti-GFP (right top panel) or anti-CK2α mAb (right bottom panel). The position
of the indicated proteins is highlighted by arrows. The IgG light and heavy chains are
indicated with (*) and (**) respectively.
Fig. 5. CK2 can phosphorylate ppUL44 residue S415 dependent on phosphorylation at
S418. The indicated peptides were incubated with recombinant CK2 in the presence of
[33P]-γATP at 37 °C for the indicated times and the incorporated radioactivity measured
by scintillation counting as described in the Materials and methods section.
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be targets of a phosphorylation cascade triggered by CK2 phosphory-
lation of S413, with negative charge at the site rendering S418 an
optimal consensus site for CK1 phosphorylation (Marin et al., 1994b;
Pulgar et al., 1999). In turn, phosphorylation of S418 (EESpDSEDSp418)
would introduce a negative charge at position +3 of residue S415,
which would then become a potential phosphorylation site for CK2
(Pinna, 2002). Indeed, in the accompanying article Silva and coworkers
report that residues S413, S415 and S418 are phosphorylated to a high
extent during viral infection (Silva et al., 2011). We tested our
hypothesis using synthetic peptides and recombinant kinases for in
vitro phosphorylation assays. First, we tested whether phosphorylation
of S413 by CK2 could render S418 a substrate for CK1-mediated
phosphorylation. To this aim, we incubated a peptide corresponding to
ppUL44 C2N motif – p6; ppUL44(410–433) –with ATP in the presence
or in the absence of recombinant CK2. Subsequently, we addedFig. 4. CK1 dependent phosphorylation of ppUL44-derived peptides can be primed by CK2. (A
or in the absence of CK2 as priming kinase at 37 °C for 90 min, as indicated. Subsequently, C
37 °C for 60 min. (B) Different amounts of peptide p6 were incubated with CK2 in the presenc
phosphorylation. (C) Different amounts of phosphopeptide p8 were incubated with CK1δ
Menten kinetic of phosphorylation. (D) Phosphorylation of peptide p6 and phosphopeptide
The incorporated radioactivity levels are expressed as a percentage of that incorporated by th
incorporated in the absence of peptides. See the Materials and methods section for details.recombinant CK1δ in the presence of ATP and [33P]-γATP, and then
measured the amount of incorporated radioactivity. Importantly,
incubation with CK1δ resulted in a signiﬁcant amount of 33P being
incorporated inp6, dependent onpre-incubationwith recombinantCK2
(see Fig. 4A). That the incorporated 33P was not due to residual CK2
activity was indicated by the lack of 33P incorporation when CK1δ was
omitted from the reaction. To conﬁrm the results, we generated a new
synthetic peptide – p8; ppUL44(410–433) pS413 – and tested its ability
to be phosphorylated by CK1δ. We also determined the apparent Km for
CK1δ mediated phosphorylation of p8, and that relative to CK2-
mediated phosphorylation of p6. Our results (see Fig. 4B and C) indicate
that CK1 phosphorylates peptide p8 with an apparent Km of ~100 μM,
comparable to that calculated for CK2 and peptide p6. Since different
CK1 isoforms exhibit different substrate speciﬁcity, we also attempted
to determine if particular CK1 isoforms could preferentially phosphor-
ylate ppUL44. Both CK1α and CK1δ, but not CK1γ, could phosphorylate
the p8 peptide to levels comparable to a control peptide (Fig. 4D).
Finally, we decided to test whether, in turn, CK1-mediated phos-
phorylation of S418 could generate a new target site for CK2-mediated
phosphorylation at residue S415. We compared the ability of CK2 to
phosphorylate peptide p9; ppUL44(410–420)S413E pS418, mimicking
phosphorylation at both S413 and S418, and peptide p8 (Fig. 5).
Signiﬁcantly, only peptide p9 could be efﬁciently phosphorylated by
CK2, suggesting that residue S415 can become a target of CK2 activity
once S418 has been phosphorylated, thereby strengthening the
hypothesis that phosphorylation of S413 triggers a phosphorylation
cascade which can result in phosphorylation of both S418 and S415.) Peptide p6was preincubated in a reactionmixture containing cold ATP in the presence
K1δ and 100 μM [33P]-γATP were added to the reactions and the mixtures incubated at
e of 100 μM [33P]-γATP at 37 °C for 10 min, to calculate theMichaelis–Menten kinetic of
in the presence of 100 μM [33P]-γATP at 37 °C for 10 min, to calculate the Michaelis–
p8 as compared to that of standard substrate CK1-tide, with the indicated CK1 isoforms.
e CK1-tide control substrate (RRKHAAIGDDDDAYSITA). CTRL refers to the radioactivity
263G. Alvisi et al. / Virology 417 (2011) 259–267UL44 nuclear transport can be modulated positively or negatively by
differential phosphorylation
The ppUL44 C2N motif thus appears to be the site of complex
posttranslational modiﬁcations by CK1 and CK2. Furthermore, it
selectively binds to BRCA1-binding protein 2 (BRAP2), a negative
regulator of nuclear transport of viral proteins, in a manner dependent
on negative charge at residue T427 (Fulcher et al., 2010). Although
formal proof of phosphorylation during viral infection ismissing, residue
T427 is likely to be phosphorylated (see Fig. 2), and it is an in vitro
substrate for cdk1, as shown by Silva et al., in the accompanying article
(Silva et al., 2011). Since phosphorylation in the close proximity of NLSs
is known to regulate the nuclear transport of several proteins (Alvisi et
al., 2005, 2008b) we decided to test the role of the phosphorylation
sites forming the C2N motif on ppUL44 nuclear targeting in detail.
We generated several ppUL44 point mutant derivatives containing
phosphonull and phosphomimetic mutations and analyzed their
subcellular localization when transiently expressed in mammalian
cells using CLSM (Fig. 6A). All proteins localized into the cell nucleus,
with the exception of GFP-UL44ΔNLS that lacks a functional NLS (Alvisi
et al., 2005). However, mutant derivative GFP-UL44 T427D also showed
clearly detectable cytoplasmic staining. In order to accurately quantify
the levels of nuclear accumulation for each mutant derivative, we
calculated the ratio between the nuclear and cytoplasmic ﬂuorescence
(Fn/c ratio, see Materials and methods). Our quantitative analysis
(Fig. 6B) showed that the phosphomimetic mutant GFP-UL44 S413E
accumulated in the nucleus to the same extent as GFP-UL44, whereas
the phosphonull GFP-UL44 S413A, S418A, and S415A mutant de-
rivatives all showed impaired nuclear targeting (Fn/c values 40, 75
and 90%, respectively, of that of the wild-type protein). Our resultsFig. 6. Phosphorylation at multiple sites can regulate nuclear import of ppUL44 either positi
fusion proteins and imaged by live CLSM 16 h after transfection using a 63× water immersio
both (merge) are shown. (B) Quantitative analysis for the nuclear to cytoplasmic ratio (F
Materials and methods section using the ImageJ software. Data represent the mean±SEM (n
and mutant derivatives.strongly suggest that CK2 and CK1 cooperate to phosphorylate ppUL44
C-terminal C2N motif in order to maximize nuclear import. On the
other hand, the T427Amutant derivative accumulated in the nucleus to
levels comparable to those of GFP-UL44. Intriguingly, the T427
phosphorylation site is located within ppUL44 NLS: phosphorylation
of sites in similar position relative to the NLS is known to inhibit nuclear
import of viral proteins such as v-Jun and Simian Virus SV40 large
tumor antigen (SV40 T-Ag) (Jans et al., 1991; Tagawa et al., 1995).
Consistent with this, the GFP-UL44 D427 phosphomimetic derivative
showed strongly reduced nuclear accumulation (b10%) compared to
wild-type GFP-UL44.
Role of ppUL44 C-terminal phosphorylation in oriLyt-dependent DNA
replication
Because ppUL44 is essential for viral replication (Ripalti et al.,
1995), we decided to test whether the identiﬁed phosphorylation
sites in its C-terminus are required for oriLyt-dependent DNA
replication. HFF were transfected with the IE2 expression construct
pON2206, plus a set of plasmids encoding each of the HCMV core
replication proteins under the control of the SV40 promoter (Gao
et al., 2010), in the presence of plasmids encoding either wild-type
GFP-UL44 or point mutants for the C-terminal phosphorylation sites
(S413A, S413E, S415A, S418A, T427A, or T427D) under the control of
the HCMV IE promoter. Replication of input plasmid was detected by
treatment of DNA extracted from transfected cells with DpnI, which
cleaves only dam-methylated input DNA (Anders et al., 1992). As
expected, a DpnI-resistant replication product was detected in the
presence of wild-type GFP-UL44 (Fig. 7). In contrast, oriLyt-mediated
DNA replicationwas not detected after transfection of GFP-UL44ΔNLS,vely or negatively. (A) COS-7 cells were transfected to express the indicated GFP-UL44
n objective. The bright ﬁeld (BF) and the green (GFP) channels, with a merged image of
n/c) for CLSM images such as those shown in panel A, performed as described in the
N50). Asterisks denote statistically signiﬁcant differences (pb0.05) between wild-type
Fig. 7. Importance of ppUL44 C2Nmotif phosphorylation sites for oriLyt dependent DNA
replication. HFF cells were transiently transfected with the pSP50 plasmid, which
contains the HCMV oriLyt DNA replication origin, a set of plasmids expressing all other
essential HCMV replication proteins under the control of the SV40 promoter, as well as
plasmids expressing GFP tagged versions of ppUL44 bearing the indicated mutations.
After DNA extraction and digestion with DpnI, undigested, replicated DNA was
visualized by Southern blotting.
264 G. Alvisi et al. / Virology 417 (2011) 259–267consistent with the idea that ppUL44 nuclear targeting is essential for
its function as the processivity factor of the DNA polymerase
holoenzyme (Silva et al., 2010). All the phosphonull and phosphomi-
metic mutants for residues S413, S415 and S418 tested, efﬁciently
trans-complemented oriLyt-dependent DNA replication, whereas
transfection of either the T427A non-phosphorylatable or the T427D
phosphomimetic mutant derivatives resulted in decreased oriLyt-
mediated DNA replication, suggesting that this residue might be
important for viral DNA replication.Discussion
Although HCMV ppUL44 was identiﬁed as a phosphoprotein from
lysates of infected cells thirty years ago (Gibson et al., 1981), the
nature and functional signiﬁcance of its phosphorylation have proved
elusive until now. More recently, the viral kinase UL97 was shown to
be capable of phosphorylating ppUL44 (Krosky et al., 2003; Marschall
et al., 2003). As we show here for the ﬁrst time, however, it is clear
that cellular kinases are also able to interact with and phosphorylate
ppUL44. Here we identify four phosphorylation sites that cluster at
the C-terminus of ppUL44 in close proximity to the NLS and
differently regulate its activity. These sites are strongly conserved
among β-herpesviruses and form the C2N (CK2 and NLS) motif, which
is functionally analogous to the CcN motif ﬁrstly described in SV40
T-Ag (Alvisi et al., 2005; Jans et al., 1991). Both motifs comprise three
serine residues located upstream of the NLS (S413, S415 and S418 in
ppUL44), that act synergistically in enhancing protein nuclear import,
through the concerted action of CK2 and other cellular kinases, which
in the case of ppUL44 include CK1 (Hubner et al., 1997; Xiao et al.,
1997). Although we cannot exclude that also other kinases can
phosphorylate the aforementioned sites (see also the accompanying
article (Silva et al., 2011)), several lines of evidence – beside the ones
reported here – suggest that CK2 is the main kinase responsible for
phosphorylating S413 and S418. First, CK2 is an atypical, constitu-
tively active kinase, and for this reason viruses often exploit it to
ensure phosphorylation of their proteins (Alvisi et al., 2008b; El-
Guindy and Miller, 2004; Guerra and Issinger, 2008; Hubner et al.,
1997; Koffa et al., 2003; Sivachandran et al., 2010); secondly, CK2 is a
component of the infectious viral particle and its activity is enhanced
upon viral infection (Nogalski et al., 2007), resulting in phosphorylation
of several HCMVproteins (Barrasa et al., 2005; Gao and Pari, 2009; Jarvis
et al., 2004). Finally, the CK2 holoenzyme can be immunoprecipitated
with another member of the HCMV replication complex, pUL84 (Gao
and Pari, 2009) that in turn interacts with ppUL44 (Gao et al., 2008;
Strang et al., 2009), and treatment with a CK2 speciﬁc inhibitor reduces
NLS activity (Alvisi et al., 2005). The similarity between the ppUL44and T-Ag phosphorylation-regulated NLSs is strengthened by the
presence of a T residue, located close to the NLS, that negatively
regulates their nuclear import (Fulcher et al., 2010; Jans et al., 1991). In
both cases, phosphorylation of this site by cdk1 (Jans et al., 1991; Silva
et al., 2011), enables interaction with the BRAP2 negative regulator of
nuclear import, and results in cytoplasmic retention (Fulcher et al.,
2010).
The reason why HCMV has evolved such a complex mechanism
with enhancing and inhibitory phosphorylation sites to regulate the
nuclear import rate of its DNA polymerase processivity factor is
unclear, but may relate to the fact that ppUL44 is involved in
facilitating the nuclear import of other viral components important
for viral replication that associate with it, including the DNA
polymerase catalytic subunit UL54 and the uracil-DNA glycosylase
UL114 (Alvisi et al., 2006c; Prichard et al., 2005). Thus, precise
modulation of ppUL44's nuclear import rate through multiple
phosphorylation events might be critical to regulate the assembly of
the viral replication fork (Alvisi et al., 2008b; Fulcher and Jans, 2011).
Furthermore, ppUL44 accumulates to very high levels at late times
after infection, when DNA replication is accomplished (Geballe et al.,
1986; Stinski, 1978), and it is therefore believed to perform additional
tasks during HCMV replication besides its role as a processivity factor
(Isomura et al., 2007). Indeed, ppUL44 also possesses transactivating
properties (Boccuni et al., 1998; Isomura et al., 2008), and recombi-
nant ppUL44 can mediate cell-adhesion via a RGD sequence (Loh
et al., 2000). In keeping with its eclectic nature, ppUL44 binds several
cellular and viral proteins (Strang et al., 2010). Consistently with this
variety of functions and interactors, ppUL44's subcellular distribution
changes during viral infection: the protein accumulates to nuclear
replication compartments at early times post infection, whereas it is
also detectable on the nuclear rim and in the cytoplasm at later times
post infection (Iwayama et al., 1994; Plachter et al., 1992). It is
therefore possible that regulation of the nuclear import rate by
phosphorylation facilitates the different distribution of ppUL44 inside
the infected cell (Alvisi et al., 2008b). The nuclear import rate of
ppU44 might also inﬂuence its ability to interact with speciﬁc
partners, with rapidly accumulating ppUL44 being less likely to bind
cytosolic proteins, as compared with slower accumulating forms. In
addition, it is also possible that its phosphorylation state modulates
the binding afﬁnity between ppUL44 and its interactors, as reported
for the IMPα/β heterodimer [whose binding to ppUL44 is facilitated
by negative charge on S413 (Alvisi et al., 2005)] and for BRAP2
[dependent on negative charge on T427 (Fulcher et al., 2010)].
The biological relevance of ppUL44 phosphorylation-regulated
nuclear import is highlighted by two recent reports from Silva and
coworkers: in a ﬁrst study they demonstrated that deletion of UL44 C-
terminal domain results in a virus unable of replicating (Alvisi et al.,
2005; Silva et al., 2010). In such virus, ppUL44 was mainly prevented
from accumulating into the nucleus, consistently with the absence of
the C-terminally located NLS (Alvisi et al., 2005; Silva et al., 2010).
However, restoration of nuclear targeting by fusion of the SV40 Tag
NLS (devoid of its regulator elements) to ppUL44 was not sufﬁcient to
restore viral replication (Silva et al., 2010). In a second study, as
reported in the accompanying article (Silva et al., 2011), they showed
that residues S413, S415 and S418 are highly phosphorylated in
HCMV-infected HFF, and that a triple phosphonull substitution of
these residues also strongly impaired nuclear targeting of ppUL44 and
viral replication. These reports, taken together with our data showing
that phosphorylation of S413 triggers a phosphorylation cascade
involving S418 and S415 to enhance ppUL44 nuclear targeting,
strongly suggest that ppUL44 regulated nuclear import is crucial for
viral replication. Intriguingly, the C-terminus of Herpes Simplex Virus
pUL42 that also contains a NLS, but whose activity is not regulated by
phosphorylation, is dispensable for viral replication (Alvisi et al.,
2008a; Gao et al., 1993). However, phosphonull mutations of the
residues S413, S415 and S418 of UL44 have no effect on oriLyt-
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the six HCMV core DNA replicating proteins (ppUL44, pUL54, pUL57,
pUL70, pUL102, and pUL105) are expressed under the control of
constitutive promoters in the presence of IE2 (see Fig. 7). This is not
surprising, since the complete ppUL44 C-terminus (residues 291–433)
is also dispensable in such trans-complementation assays [despite
being absolutely required for viral replication in cell culture (Kim and
Ahn, 2010; Silva et al., 2010)]. Thus, it appears that ppUL44 regulated
nuclear import does not play an important role in regulating the
assembly of the core replicating proteins, at least when the other viral
proteins are not expressed.
The evidence that both phosphonull (T427A) and phosphomimetic
(T427D) mutations of residue T427 decrease the ability of ppUL44 to
trans-complement oriLyt-dependent DNA replication implies that the
role of phosphorylation of the ppUL44 C-terminusmay extend beyond
the regulation of its nuclear import. Whereas the effect of the
phosphomimetic T427D substitution can be attributed to its inhibition
of ppUL44 nuclear targeting, the phosphonull T427A substitution does
not affect nuclear accumulation, suggesting that T427 phosphoryla-
tion could regulate protein–protein interactions required for DNA
replication. Indeed, ppUL44 C-terminus is involved in binding to
cellular and viral proteins and the phosphorylation status of T427
could modulate such interactions, as in the case of BRAP2 (Alvisi et al.,
2005; Fulcher et al., 2010; Kim and Ahn, 2010; Ranneberg-Nilsen
et al., 2008). Furthers studies will be performed to characterize the
role of residue T427 in HCMV life cycle.
Materials and methods
Analysis of sequence motifs within ppUL44
Putative phosphorylation sites within the ppUL44 coding sequence
and cellular kinases potentially phosphorylating themwere identiﬁed
using the NetPhos and GPS 2.1 software, respectively (Blom et al.,
1999; Xue et al., 2008).
Materials
Solvents and coupling reagents for peptide synthesis and protein
sequencing were from Applied Biosystems. Reagents for solid-phase
peptide synthesis were purchased from Novabiochem. All other
analytical grade reagents were from Sigma-Aldrich. [33P]-γATP
(3000 Ci/mmol) was purchased from Amersham Pharmacia Biotech.
[32P]orthophosphate was from PerkinElmer Life Sciences.
Expression plasmids
Plasmid pCDNA-UL44-FLAG (Marschall et al., 2003)was provided by
Manfred Marschall (Erlangen). The expression plasmids encoding
GFP-UL44 fusion protein in mammalian cells have been described
previously (Alvisi et al., 2005, 2006a). Plasmids pDNR207-UL44(2–433;
S413A), pDNR207-UL44(2–433; S413E), pDNR207-UL44(2–433;
S415A), pDNR207-UL44(2–433; S418A), pDNR207-UL44(2–433;
T427D) and pDNR207-UL44(2–433; T427A) were all generated using
the QuikChange mutagenesis kit (Stratagene) and appropriate primer
pairs with plasmid pDNR207-UL44(2–433) as a template. Entry clones
were used to perform LR recombination reactions with the Gateway
system compatible expression (DEST) plasmids pDEST15 (Invitrogen)
and pEPI-DEST-GFP (Poon et al., 2005), according to themanufacturer's
recommendations. The integrity of all constructswas conﬁrmed byDNA
sequencing (MWG-BIOTECH).
Cell culture and transfection
COS-7 and HEK293-T cells were maintained in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 5% (v/v) fetal bovineserum (FBS), 50 U/ml penicillin, 50 U/ml streptomycin and 2 mM L-
glutamine. Human foreskin ﬁbroblasts (HFF) were maintained in the
same medium, except with 10% FBS. For live cell imaging by CLSM,
cells were trypsinized and 8×104 cells were seeded onto coverslips in
6-well plates 1 day before transfection, which was performed using
Lipofectamine 2000 (Invitrogen) according to the manufacturer's
speciﬁcations. For immunoprecipitation and coimmunoprecipitation
experiments, cells were trypsinized and 2×105 cells were seeded onto
a 6-well plate 1 day before transfection. For coimmunoprecipitation
experiments, 16 h after seeding completemediawas replaced by serum
free-media, in order to synchronize cell growth. Transfection was
performed 8 h later with Lipofectamine 2000, in the absence of serum
according to the manufacturer's speciﬁcations. 8 h after transfection,
complexes were removed and replaced by complete media.Immunoprecipitation and radiolabeling of ppUL44
ppUL44 fusion proteins were immunoprecipitated using the
magnetic μMACS Protein G Microbeads in combination with μMACS
column technology (Miltenyi Biotech) and an anti-FLAG (SIGMA)
monoclonal antibody (mAb), according to the recommendations of
the manufacturer. For ppUL44 phosphoradiolabeling, 6×105 COS-7
cells were transfected to express ppUL44 fusion proteins or mock-
transfected. 24 h post-transfection, [32P]orthophosphate was added
to the media (100 μCi/ml) and cells were incubated for further 24 h.
Cells were then washed twice with cold PBS, and cell lysates prepared
after incubation for 30 min on ice in 300 μl lysis buffer [150 mM NaCl,
1% Triton X-100, 50 mM Tris–HCl (pH 8.0), and complete protease
inhibitors (Roche)]. Cell debris were removed by centrifugation at
14,000 rpm for 10 min at 4 °C, and the cleared lysates incubated for
30 min at 4 °C with 20 μl of Protein G Microbeads (Miltenyi Biotech)
and 1 μg of the anti-FLAG monoclonal antibody. The mixtures were
then loaded on μMACS columns (Miltenyi Biotech), which were pre-
equilibrated with 200 μl of lysis buffer, washed 4 times with 200 μl of
lysis buffer, and then eluted with 50 μl of preheated elution buffer
[50 mM Tris–HCl (pH 6.8), 50 mM dithiothreitol (DTT), 1% sodium
dodecyl sulfate (SDS), 0.005% bromophenol blue, and 10% glycerol]. A
total of 15 μl of the mixture containing the eluted proteins was loaded
onto 4–20% bis-trisacrylamide NuPage precast gels (Invitrogen) and
separated by polyacrylamide gel electrophoresis (PAGE). Electropho-
retically separated proteins were then transferred to a Whatman
nitrocellulose paper as previously described (Alvisi et al., 2006a). The
membrane was blocked in buffer A [5% bovine serum albumin (BSA)
(w/v) and TBS 1×] for 1 h at room temperature and washed 3 times
with buffer B (0.05% Tween and TBS 1×). Detection of radiolabeled-
ppUL44 was performed by autoradiography by incubating the
membrane with a Kodak ﬁlm for 16 h at−80 °C. The ppUL44 protein
was detected by incubating themembraneswith the anti-FLAGmouse
primary mAb (SIGMA; 1:1000) and a peroxidase-coupled secondary
antibody (SIGMA; 1:400). The immunoblots were developed with
TBS/Methanol/H2O2 and 4-chloronaphthol.Coimmunoprecipitation of ppUL44 with cellular kinases
COS-7 cells expressing GFP-UL44 were treated as above with the
exception that cell lysates were incubated with anti-GFP monoclonal
antibody (1 μg, Santa Cruz Biotechnology) followed by immunoprecipi-
tationusingProteinGMicrobeadsandμMACScolumns(MiltenyiBiotech).
After PAGE and transfer to nitrocellulose, coimmunoprecipitated
proteins were revealed by incubating the membrane with the anti-
GFP (Santa Cruz Biotechnology) and anti-CK2 α subunit (Upstate
Biotechnology) antibodies. The immunoblotswere developed using ECL
plus (Amersham Pharmacia Biotech), according to the manufacturer's
recommendations.
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6His-UL44 fusion proteins were expressed and puriﬁed as
previously (Alvisi et al., 2005). Human recombinant CK2 α and β
subunits were expressed in E. coli, and the CK2 holoenzyme
reconstituted and puriﬁed as described (Sarno et al., 1996). Human
recombinant CK1 isoforms were expressed and puriﬁed as previously
(Ferrarese et al., 2007).
Peptide synthesis
The peptide substrates p1–p9 (see Table 1 for sequence details)
reproducing the ppUL44 putative phosphorylation sites were
synthesized by a solid-phase method using an automatic peptide
synthesizer (Model 431-A; Applied Biosystems) following a ﬂuoren-
9-ylmethoxycarbonyl (Fmoc) procedure (Fields and Noble, 1990)
employing 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexaﬂuorophosphate (HBTU) and 1-hydroxybenzotriazole (HOBt)
in the presence of diisopropyl ethyl amine as coupling reagents. Rink
Amide PEGA resin and Amino PEGA resins (Novabiochem) were used to
generate solublepeptideswith carboxyl-terminal amide (p1–p5) and the
anchored peptide p7, respectively. Fmoc-Ser-[PO(O-benzyl)OH]-OHwas
employed as a building block in the assembly of the phosphopeptides p8
and p9. All peptides were cleaved from the resins and deprotected by
treatmentwith a solution containing TFA/H20/thioanisole/ethanedithiol/
phenol (10 ml/0.5 ml/0.5 ml/0.25 ml/750 mg) for 2.5 h. Crude peptides
were puriﬁed by preparative reverse phase HPLC. Molecular masses of
the peptides were conﬁrmed by mass spectroscopy with direct infusion
on a Micromass ZMD-4000 Mass Spectrometer (Waters–Micromass).
The purity of the peptides was 95–98% as evaluated by analytical reverse
phase HPLC.
In vitro phosphorylation assays
Synthetic peptide substrates derived from the ppUL44 sequence
were phosphorylated by incubation in a solution (30 μl ﬁnal volume)
containing50 mMTris/HCl buffer (pH7.5), 10 mMMgCl2, 100 mMNaCl,
and 100 μM [33P]-γATP (speciﬁc radioactivity 1500–2000 cpm/pmol).
The reaction was started with the addition of protein kinases and
stopped by spotting onto phosphocellulose ﬁlters taking advantage of
the basic residues of the peptides and cooling in ice. Filters werewashed
in 75 mM phosphoric acid four times and dried before counting in a
scintillation counter. Incorporated radioactivity was normalized against
a peptide substrate of CK1α, CK1δ, and CK1γ1: RRKHAAIGDDDDAYSITA,
derived from inhibitor-2 of protein phosphatase-1 (Marin et al., 1994a).
Initial rate data were ﬁtted to the Michaelis–Menten equation with the
Prism software (GraphPad Software) to obtain apparent Km and Vmax
values. When the peptide substrates were substituted by a recombinant
6His-UL44 fusion protein, the phosphorylation reaction was stopped
by the addition of concentrated Laemmli buffer and boiling, followed
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), Coomassie
staining, and autoradiography (PerkinElmer's Cyclone Plus Storage
Phosphor System).
Solid-phase Edman sequencing
Aliquots (0.5 mg, ~200 nmol) of synthetic peptide substrate (p7)
covalently bound to the beads employed for solid-phase synthesis
were phosphorylated in a 50 μl volume containing [33P]-γATP as
described above. The phosphorylated peptidyl resin was separated
from the reaction mixture by ﬁltration and exhaustively washed.
Radiolabeled peptidyl resin was subsequently resuspended in
methanol, and a few beads, corresponding to 1000–10,000 cpm,
were spotted onto a micro-TFA ﬁlter (Applied Biosystems) placed
inside the cartridge of a Procise HT 491 protein sequencer (Applied
Biosystems) and analyzed as described (Ferrarese et al., 2007). Therecovered 33P radioactivity at every Edman sequencing cycle was
plotted against the primary sequence of the peptide substrate.
CLSM/image analysis
Subcellular localization of GFP–UL44 fusion proteins in living cells
was visualized 16 h after transfection by CLSM using an Olympus
Fluoview 1000 (Olympus), equipped with a differential interference
contrast apparatus. A heated Planapo ﬂuor 63× water immersion
objective (Nikon) was used in combination with a heated stage. The
Fn/c values were determined as described (Alvisi et al., 2005, 2006c,
2007) using the NIH ImageJ 1.62 public domain software, from single
cell measurements for each of the nuclear (Fn) and cytoplasmic (Fc)
ﬂuorescence, subsequent to the subtraction of ﬂuorescence due to
autoﬂuorescence/background.
OriLyt-dependent DNA replication trans-complementation assays
HFF were cotransfected with plasmids encoding each of the HCMV
core replication proteins under the control of the simian virus 40
(SV40) promoter, the IE2 expression construct pON2206, with or
without pEPI-GFP-UL44 expression plasmids, pGEM-oriLyt, which
contains the HCMV cloned oriLyt, using the calcium phosphate
method essentially as described (Gao et al., 2010). Total cellular
DNA was harvested 5 days post-transfection, cleaved with EcoRI and
DpnI, and electrophoretically separated on a 0.8% agarose gel. The
DNA was subsequently transferred to a Zeta-Probe nylon membrane
and hybridized with 32P-labeled pGEM7zf(−). The blots were imaged
as described (Gao et al., 2010).
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